Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
21 02 2019
Historique:
received: 19 07 2018
revised: 29 10 2018
accepted: 17 12 2018
pubmed: 5 2 2019
medline: 7 1 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Recent outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, along with the threat of a future coronavirus-mediated pandemic, underscore the importance of finding ways to combat these viruses. The trimeric spike transmembrane glycoprotein S mediates entry into host cells and is the major target of neutralizing antibodies. To understand the humoral immune response elicited upon natural infections with coronaviruses, we structurally characterized the SARS-CoV and MERS-CoV S glycoproteins in complex with neutralizing antibodies isolated from human survivors. Although the two antibodies studied blocked attachment to the host cell receptor, only the anti-SARS-CoV S antibody triggered fusogenic conformational changes via receptor functional mimicry. These results provide a structural framework for understanding coronavirus neutralization by human antibodies and shed light on activation of coronavirus membrane fusion, which takes place through a receptor-driven ratcheting mechanism.

Identifiants

pubmed: 30712865
pii: S0092-8674(18)31642-8
doi: 10.1016/j.cell.2018.12.028
pmc: PMC6751136
mid: NIHMS1041755
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
Antibodies, Viral 0
Receptors, Virus 0
Spike Glycoprotein, Coronavirus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1026-1039.e15

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201700059C
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120553
Pays : United States
Organisme : NIH HHS
ID : S10 OD021832
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Structure. 2019 Jan 2;27(1):134-139.e3
pubmed: 30344107
PLoS Pathog. 2017 Nov 30;13(11):e1006698
pubmed: 29190287
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Nat Struct Mol Biol. 2016 Oct;23(10):899-905
pubmed: 27617430
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):136-53
pubmed: 25615868
J Virol. 2009 Nov;83(21):11133-41
pubmed: 19706706
Elife. 2016 Nov 15;5:
pubmed: 27845625
J Virol. 1998 Jan;72(1):497-503
pubmed: 9420251
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357
pubmed: 28807998
Nat Methods. 2012 Sep;9(9):853-4
pubmed: 22842542
Cell Res. 2017 Jan;27(1):119-129
pubmed: 28008928
J Struct Biol. 2009 Apr;166(1):95-102
pubmed: 19263523
Nat Struct Mol Biol. 2015 Nov;22(11):833-4
pubmed: 26581513
Lancet Infect Dis. 2014 Feb;14(2):140-5
pubmed: 24355866
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nature. 2013 Aug 8;500(7461):227-31
pubmed: 23831647
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8
pubmed: 26216974
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Elife. 2016 Sep 26;5:
pubmed: 27669148
J Virol. 2018 Jan 30;92(4):
pubmed: 29093093
J Proteome Res. 2013 Mar 1;12(3):1520-5
pubmed: 23347405
Curr Protoc Bioinformatics. 2012 Dec;Chapter 13:Unit13.20
pubmed: 23255153
Cell Host Microbe. 2014 Sep 10;16(3):328-37
pubmed: 25211075
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
J Virol. 2015 Sep;89(17):9119-23
pubmed: 26063432
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2184-95
pubmed: 15572771
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
J Struct Biol. 2009 May;166(2):205-13
pubmed: 19374019
PLoS Pathog. 2014 Nov 06;10(11):e1004502
pubmed: 25375324
Bio Protoc. 2016 Dec 5;6(23):
pubmed: 28018942
J Virol. 2014 Sep 1;88(17):9538-52
pubmed: 24965452
IUCrJ. 2019 Jan 01;6(Pt 1):5-17
pubmed: 30713699
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6
pubmed: 19321428
J Mol Biol. 2003 Oct 31;333(4):721-45
pubmed: 14568533
J Virol. 2004 Jul;78(13):6938-45
pubmed: 15194770
Nature. 2016 Mar 3;531(7592):118-21
pubmed: 26935699
Cell. 2016 May 5;165(4):813-26
pubmed: 27114034
Emerg Infect Dis. 2013 Nov;19(11):1819-23
pubmed: 24206838
Nat Med. 2004 Aug;10(8):871-5
pubmed: 15247913
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157-11162
pubmed: 29073020
PLoS Pathog. 2018 Apr 23;14(4):e1007009
pubmed: 29684066
Nature. 2016 Mar 3;531(7592):114-117
pubmed: 26855426
Ultramicroscopy. 2013 Dec;135:24-35
pubmed: 23872039
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
pubmed: 26976607
Anal Biochem. 2009 May 1;388(1):115-21
pubmed: 19233118
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Virology. 2010 Apr 10;399(2):257-69
pubmed: 20129637
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11
pubmed: 16929101
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2210-21
pubmed: 15572774
Immunity. 2018 Apr 17;48(4):799-811.e9
pubmed: 29669253
Elife. 2018 Nov 09;7:
pubmed: 30412051
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Virology. 2007 May 10;361(2):304-15
pubmed: 17210170
J Virol. 2008 Apr;82(7):3220-35
pubmed: 18199635
Angew Chem Int Ed Engl. 2014 Sep 22;53(39):10367-71
pubmed: 25115701
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
J Gen Virol. 2003 Dec;84(Pt 12):3291-3303
pubmed: 14645910
Nat Commun. 2017 Apr 10;8:15092
pubmed: 28393837
Cell Rep. 2018 Aug 21;24(8):1958-1966.e5
pubmed: 30134158
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7320-7325
pubmed: 29941589
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
PLoS Pathog. 2018 Aug 13;14(8):e1007236
pubmed: 30102747
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
J Virol. 2017 Oct 25;92(4):
pubmed: 29070693
Cell Rep. 2016 Aug 30;16(9):2327-38
pubmed: 27545891
Mol Cell Proteomics. 2003 May;2(5):346-56
pubmed: 12775768
Cell. 2015 Sep 10;162(6):1379-90
pubmed: 26359989
Emerg Infect Dis. 2005 Dec;11(12):1860-5
pubmed: 16485471
Nat Commun. 2016 Nov 22;7:13473
pubmed: 27874853
Acta Crystallogr D Struct Biol. 2018 Apr 1;74(Pt 4):279-289
pubmed: 29652255
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
pubmed: 25288733
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12262-12267
pubmed: 27791014
J Struct Biol. 2007 Jan;157(1):281-7
pubmed: 16963278
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
Sci Rep. 2018 Oct 24;8(1):15701
pubmed: 30356097

Auteurs

Alexandra C Walls (AC)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

Xiaoli Xiong (X)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

Young-Jun Park (YJ)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

M Alejandra Tortorici (MA)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA; Institute Pasteur & CNRS UMR 3569, Unité de Virologie Structurale, 75015, Paris, France.

Joost Snijder (J)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

Joel Quispe (J)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA.

Elisabetta Cameroni (E)

Humabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.

Robin Gopal (R)

National Infection Service, Public Health England, London NW9 5HT, UK.

Mian Dai (M)

Crick Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Antonio Lanzavecchia (A)

Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.

Maria Zambon (M)

National Infection Service, Public Health England, London NW9 5HT, UK.

Félix A Rey (FA)

Institute Pasteur & CNRS UMR 3569, Unité de Virologie Structurale, 75015, Paris, France.

Davide Corti (D)

Humabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.

David Veesler (D)

Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA. Electronic address: dveesler@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH